Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

EMD-221963, a representative NHE-3 inhibitor from Merck KGaA

May 17, 2001

NDA filed in Hong Kong for NexMed's ED treatment

May 16, 2001

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

May 11, 2001

Watson seeks FDA approval for overactive bladder treatment

May 4, 2001

Kissei and Daiichi will codevelop and comarket BPH Rx in Japan

May 3, 2001

Cialis demonstrates extended duration in clinical trials in ED

May 3, 2001

Tolterodine ER shows improved efficacy and safety

May 2, 2001

Senetek's Invicorp well tolerated for ED in hypertensive patients

April 25, 2001

Senetek's Invicorp safe and effective for severe ED in diabetics

April 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...